ITGA5 and hepatocellular carcinoma: Those results suggested that angiogenetic‐related genes possess prognostic power for response to Sorafenib treatment in HCC patients, and we hypothesized that hypoxic character may be affected by ITGA5 and corresponding β subunit, especially ITGB1 (Figure S1).